Senior Regulatory Intelligence Manager – China Lead
Novo Nordisk A/S
Ms. Anette Hjelmsmark holds a position as Senior Regulatory Intelligence Manager at Novo Nordisk A/S headquarters. During her 27 years tenure within the pharmaceutical industry she has collected in depth experience from across Quality Assurance, Research & Development, and Regulatory Affairs.
Anette has for several years been heavily engaged in the European trade association EFPIA (European Federation of Pharmaceutical Industries and Associations) as chair and member of various international regulatory working groups. She currently chairs the EFPIA China Regulatory Network and is for several years member of the International Regulatory Expert Group (IREG) covering several regions and countries. In IREG she is heavily engaged in the ICH E17 task force which focuses on the implementation progress.
Anette is a faculty member at the University of Copenhagen Master of Industrial Drug Development. In 2019 and 2021 she contributed to the APEC MRCT training at Peking University.
She holds a Master of Science from the Royal Veterinary and Agricultural University in Copenhagen, Denmark and she made her thesis at the Carlsberg Research Centre. In 2014 she achieved a diploma in “Managing Medical Product Innovation” at Copenhagen Business School.